Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7W9R

Crystal structure of V30M-TTR in complex with naringenin derivative-18

Summary for 7W9R
Entry DOI10.2210/pdb7w9r/pdb
DescriptorTransthyretin, (2~{R})-2-[3,5-bis(chloranyl)-4-oxidanyl-phenyl]-5,7-bis(oxidanyl)-2,3-dihydrochromen-4-one (3 entities in total)
Functional Keywordsamyloidosis, complex, inhibitor, thyroxine, transport protein
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight35367.45
Authors
Katayama, W.,Shimane, A.,Nabeshima, Y.,Yokoyama, T.,Mizuguchi, M. (deposition date: 2021-12-10, release date: 2022-12-14, Last modification date: 2023-11-29)
Primary citationMizuguchi, M.,Nakagawa, Y.,Inui, K.,Katayama, W.,Sawai, Y.,Shimane, A.,Kitakami, R.,Okada, T.,Nabeshima, Y.,Yokoyama, T.,Kanamitsu, K.,Nakagawa, S.,Toyooka, N.
Chlorinated Naringenin Analogues as Potential Inhibitors of Transthyretin Amyloidogenesis.
J.Med.Chem., 65:16218-16233, 2022
Cited by
PubMed Abstract: Misfolding and aggregation of transthyretin are implicated in the fatal systemic disease known as transthyretin amyloidosis. Here, we report the development of a naringenin derivative bearing two chlorine atoms that will be efficacious for preventing aggregation of transthyretin in the eye. The amyloid inhibitory activity of the naringenin derivative was as strong as that of tafamidis, which is the first therapeutic agent targeting transthyretin in the plasma. X-ray crystal structures of the compounds in complex with transthyretin demonstrated that the naringenin derivative with one chlorine bound to the thyroxine-binding site of transthyretin in the forward mode and that the derivative with two chlorines bound to it in the reverse mode. An ex vivo competitive binding assay showed that naringenin derivatives exhibited more potent binding than tafamidis in the plasma. Furthermore, an in vivo pharmacokinetic study demonstrated that the dichlorinated derivative was significantly delivered to the eye.
PubMed: 36472374
DOI: 10.1021/acs.jmedchem.2c00511
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.997 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon